Clinicoepidemiological Profile of Breakthrough COVID-19 Infection Following COVID-19 Vaccination among Health Science University (deemed to be) Faculty and Students in Mysuru

Le résumé fourni par la source

purpose is to improve health," according to the World Health Organization (WHO).7 "Vaccines are biologics that provide active adaptive immunity against specific diseases."8 The pandemic, secondary waves of IntroductIonThe severe acute respiratory syndrome (SARS) coronavirus pandemic is considered one of the unprecedented public health emergencies of the 21st century.In December 2019, adults in Wuhan, China, began exhibiting to the neighborhood hospitals with acute pneumonia of unknown origin. 1 The cause of the sickness was later discovered as a new strain of coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the condition has been dubbed as coronavirus disease 2019 or COVID-19.2 Due to geographical disparities and the transmission of several coronavirus variants, the epidemic development in India is highly complicated.3 The global infection fatality rate ranges from 0.15 to 0.20% (0.03-0.04% in those under the age of 70), with significant regional variation due to age distribution, institutionalization rates, economic disparities, population-level clinical risk profiles, public health initiatives, and access to health care.4 Quarantine, contact tracing, screening, and isolation are efficient COVID-19 preventive strategies, especially when combined.5 Healthcare workers (HCWs) are among the most vulnerable to infection.6 HCWs are on the front lines of this worldwide catastrophe, "All those involved in initiatives whose primary 1

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.